Hypoxia inducible factor-1a-mediated activation of survivin in cervical cancer cells

Journal of Obstetrics and Gynaecology Research

Volumn 39, Issue 2, 2013, Pages 555-563

  Bai, Haitao ^a   Ge, Shengfang ^b   Lu, Jian ^b   Qian, Guanxiang ^b   Xu, Rang ^b  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cervical cancer; Hypoxia; Hypoxia inducible factor 1a; Survivin

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; LUCIFERASE; SURVIVIN;

ADULT; AGED; ARTICLE; CANCER CELL; CELL HYPOXIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE INDUCTION; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVIN GENE; TRANSCRIPTION REGULATION; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING;

AGED; CARCINOMA; CELL HYPOXIA; CELL LINE, TUMOR; CERVIX UTERI; FEMALE; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; INHIBITOR OF APOPTOSIS PROTEINS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; NEOPLASM STAGING; PROMOTER REGIONS, GENETIC; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84875256838     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2012.01995.x     Document Type: Article

References (26)

1. Brahimi-Horn MC, Chiche J, Pouyssegur J. Hypoxia and cancer. J Mol Med 2007; 85: 1301-1307.
2. Hopfl G, Ogunshola O, Gassmann M. HIFs and tumors -causes and consequences. Am J Physiol Regul Integr Comp Physiol 2004; 286: R608-R623.
3. Maynard MA, Ohh M. The role of hypoxia-inducible factors in cancer. Cell Mol Life Sci 2007; 64: 2170-2180.
4. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev 2003; 3: 721-732.
5. Li F, Ambrosini G, Chu EY et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-584.
6. Li F. Survivin study: What is the next waveJ Cell Physiol 2003; 197: 8-29.
7. Jiang X, Wilford C, Duensing S, Munger K, Jones G, Jones D. Participation of survivin in mitotic and apoptotic activities of normal and tumor-derived cells. J Cell Biochem 2001; 83: 342-354.
8. Lee JP, Chang KH, Han JH, Ryu HS. Survivin, a novel antiapoptosis inhibitor, expression in uterine cervical cancer and relationship with prognostic factors. Int J Gynecol Cancer 2005; 15: 113-119.
9. Wu J, Ling X, Pan D et al. Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: Evidence of survivin down-regulation associated with drug sensitivity. J Biol Chem 2005; 280: 9745-9751.
10. Zhu L, Fukuda S, Cordis G,Das DK, Maulik N. Anti-apoptotic protein survivin plays a significant role in tubular morphogenesis of human coronary arteriolar endothelial cells by hypoxic preconditioning. FEBS Lett 2001; 508: 369-374.
11. Yang L, Cao Z, Li F et al. Tumor-specific gene expression using the survivin promoter is further increased by hypoxia. Gene Ther 2004; 11: 1215-1223.
12. Ueda Y, Nakagawa T, Kubota T, Ido K, Sato K. Glioma cells under hypoxic conditions block the brain microvascular endothelial cell death induced by serum starvation. J Neurochem 2005; 95: 99-110.
13. Talks KL, Turley H, Gatter KC et al. The expression and distribution of the hypoxia-inducible factors HIF-1a and HIF-2a in normal human tissues, cancers, and tumor-associated macrophages. Am J Pathol 2000; 157: 411-421.
14. Xu R, Zhang P, Huang J, Ge S, Lu J, Qian G. Sp1 and Sp3 regulate basal transcription of the survivin gene. Biochem Biophys Res Commun 2007; 356: 286-292.
15. Zhong H, De Marzo AM, Laughner E et al. Overexpression of hypoxia-inducible factor 1 in common human cancers and their metastases. Cancer Res 1999; 59: 5830-5835.
16. Kung AL, Wang S, Klco JM, Kaelin WG, Livingston DM. Suppression of tumor growth through disruption of hypoxia-inducible transcription. Nat Med 2000; 6: 1335-1340.
17. Carmeliet P, Dor Y, Herbert JM et al. Role of HIF-1a in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature 1998; 394: 485-490.
18. Forsythe JA, Jiang BH, Iyer NV et al. Activation of vascular endothelial growth factor gene transcription by hypoxiainducible factor 1. Mol Cell Biol 1996; 16: 4604-4613.
19. Kardosh A, Soriano N, Pyrko P et al. Reduced survivin expression and tumor cell survival during chronic hypoxia and further cytotoxic enhancement by the cyclooxygenase-2 inhibitor celecoxib. J Biomed Sci 2007; 14: 647-662.
20. Wu XY, Fu ZX, Wang XH. Effect of hypoxia-inducible factor 1-a on survivin in colorectal cancer. Mol Med Rep 2010; 3: 409-415.
21. Cummins EP, Taylor CT. Hypoxia-responsive transcription factors. Pflugers Arch 2005; 450: 363-371.
22. Yu J, Zhang L, Hwang PM, Rago C, Kinzler KW, Vogelstein B. Identification and classification of p53-regulated genes. Proc Natl Acad Sci USA 1999; 96: 14517-14522.
23. Yatabe N, Kyo S, Maida Y et al. HIF-1-mediated activation of telomerase in cervical cancer cells. Oncogene 2004; 23: 3708-3715.
24. Suzuki Y, Oka K, Yoshida D et al. Correlation between survivin expression and locoregional control in cervical squamous cell carcinomas treated with radiation therapy. Gynecol Oncol 2007; 104: 642-646.
25. Koshiji M, Kageyama Y, Pete EA, Horikawa I, Barrett JC, Huang LE. HIF-1 alpha induces cell cycle arrest by functionally counteracting Myc. EMBO J 2004; 23: 1949-1956.
26. Otaki M, Hatano M, Kobayashi K, Ogasawara T, Kuriyama T, Tokuhisa T. Cell cycle-dependent regulation of TIAP/msurvivin expression. Biochim Biophys Acta 2000; 1493: 188-194.